ArticleReports (MDPI)2025

Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn's Disease: A Case Report.

Michele Campigotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.